Achieve Life Sciences, Inc.
(ACHV - NASDAQ)
8,49 USD
📋 Profilo Aziendale

Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline.

|